脱兔电竞

新闻动态

新药创制重大专项“十三五”储备力量和主要看点

2016-3-22

  制药行业最核心的竞争力来源于新药创制水平,根据FDA的公开数据,2010~2015年美国批准了209个新药品种(包括新分子实体药物NMEs和新生物制品BLAs),其中绝大部分品种来源于本国制药企业。

  YUMEIGUOBUTONG,ZHANGQIYILAIZHONGGUOZHIYAOXINGYEDEZHONGXINZAIFANGZHIYAOSHANG。ZHONGGUOYIDUBEICHENGWEIFANGZHIYAODAGUO,FANGZHIYAOSHICHANGZHANJULEGUONEIYIYAOSHICHANGDEJUEDABUFENFENE。

  BUGUOJINJINIAN,ZHONGGUOZISHANGERXIACONGZHENGFU、SHEHUI、KEYANJIGOUDAOQIYE,DOUDUIXINYAOYANFAYUELAIYUEGUANZHUHEZHONGSHI,YIXILIEDUIXINYAOLIHAODEZHENGCELUXUCHUTAI。QIZHONG,2008NIANGUOJIACHUTAIDEXINYAOCHUANGZHIZHONGDAZHUANXIANGYINGXIANGYOUWEISHENYUAN,GAIZHUANXIANGSHIJIANGUOYILAIGUOJIADUIXINYAOCHUANGZHIDEZUIDALIDUZHICHI,QIZHONGZHONGYANGCAIZHENGYUJITOURU260YIYUAN,“SHIYIWU”DE3NIANHE“SHIERWU”DEQIAN4NIANLEIJIZHONGYANGCAIZHENGTOURUDA130.5YIYUAN。

  ZAIXINYAOCHUANGZHIZHENGCEDENGDEDALIFUCHIXIA,ZHONGGUOZIZHUXINYAOCHUANGXINQUDELEJUDATUPO。JINNIANLAI,ZHONGGUOCHUANGXINYAOHUOPISHULIANGZHUBUTISHENG,“SHIERWU”5NIANLEIJIHUOPIDEYUANCHUANGXINYAODA19GE。

  SUIZHEZHENGCEDESHISHI,ZHONGGUODECHUANGXINYAOYANFANENGLIYEZAITISHENG。GENJUGONGKAIXINWENBAODAO,“SHIYIWU”QIJIANGUONEIGONGYOU16GEPINZHONGHUODEXINYAOZHENGSHU,“SHIERWU”QIJIANGONGYOU85GEPINZHONGHUODEXINYAOZHENGSHU。

脱兔电竞  BUJIUQIANZHAOKAIDE“ZHONGDAXINYAOCHUANGZHIKEJIZHONGDAZHUANXIANGZHAOKAIZONGTIZUGONGZUOHUIYI”TICHU,“SHISANWU”ZHONGDAZHUANXIANGDEYUQIMUBIAOJIKAOHEZHIBIAOSHI——YANZHI30GEXINYAO,8~10GEWEIYUANCHUANGXINGXINYAO。CONGKAOHEMUBIAOZHONGKEYIKANCHU,“SHISANWU”JIANGGENGWEIGUANZHUCHUANGXINYAODEJIAZHI。

  QINIANCHENGJIDAN

   23GEZIZHUYANFAYILEIXINYAOHUOPIQUDEXINYAOZHENGSHU,QIZHONG19GEPINZHONGYIYOUSHENGCHANPIJIAN,BUSHAOPINZHONGCHUANGXINCHENGDUDADAOGUOJISHUIPING

  HUIGU2008NIANZHIJIN,JUBIZHEDETONGJI,MUQIANZHENGSHILIXIANGDEXINYAOCHUANGZHIZHUANXIANGXIANGMUSHULIANGYIDA1525XIANG,FUGAILEXINYAOBAOKUOLINCHUANGQIAN、LINCHUANGYANJIU、ⅣQIYANJIU、CHANYEHUAYANJIUDENGDUOGEJIEDUAN。CIWAI,ZUIXINDE2016NIANGUOJIA“ZHONGDAXINYAOCHUANGZHI”KEJIZHUANXIANGKETIFUSHENDABIANYIJINGSHOUGUAN,GONGYOU122GEKETICANYULEFUSHENDABIAN,ZHEIQIZHONGYOUJIANGPEIYUCHUDUOGEYOUSHICHANGQIANJINGDECHUANGXINYAO。

  XIANGMUKAIZHANYILAI,SHOUGUOJIAZHONGDAXINYAOCHUANGZHIZHENGCEZHICHI,YIYOU23GEZIZHUYANFAYILEIXINYAOHUOPIQUDELEXINYAOZHENGSHU,QIZHONG19GEPINZHONGYIJINGQUDESHENGCHANPIJIAN,JUBEILESHENGCHANZIGE。

脱兔电竞  ZAIYISHANGSHIDE19GEYUANCHUANGYILEIXINYAOZHONG,BUSHAOPINZHONGDECHUANGXINCHENGDUDADAOLEGUOJISHUIPING,SHICHANGHUOYIYEPOWEIFENGHOU。

  YUWEIKANBI“LIANGDANYIXING”DEBEIDADEAIKETINI(KAIMEINA)SHIZHONGGUODIYIGEJUYOUWANQUANZHISHICHANQUANDEXIAOFENZIBAXIANGKANGZHONGLIUYONGYAO,YU2011NIANHUOPISHANGSHI。KAIMEINAZHUYAODINGWEIYUFEIXIAOXIBAOFEIAI,YUZHUYAOJINGPINYIRUISHAXIANGBI,QIRIZHILIAOFEIYONGGENGDI,QIELINCHUANGYANJIUXIANSHIKAIMEINAANQUANXINGGENGJIA,XIANGGUANBAODAOCHENG2015NIANKAIMEINAXIAOSHOUEYOUWANGDADAO7YIYUAN。

来源(中国医药集团网) 作者()
1234

上篇:

下篇:

联系我们
提供给您最好的
联系我们
  • 联系电话: 0931-8316041
  • 不良反应和产品咨询:
    0931-8340311
  • 举报邮箱:
    cnbglz-jijian@sinopharm.com
友情链接
友情链接